Hsp90 inhibition modulates nitric oxide production and nitric oxide-induced apoptosis in human chondrocytes

BMC Musculoskeletal Disorders

Volumn 12, Issue , 2011, Pages

  Calamia, Valentina ^a   De Andrés, Maria C ^a   Oreiro, Natividad ^a   Ruiz Romero, Cristina ^a   Blanco, Francisco J ^a,b  

^a Rheumatology Division   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

GELDANAMYCIN; HEAT SHOCK PROTEIN; HEAT SHOCK PROTEIN 90BETA; INTERLEUKIN 1BETA; NITRIC OXIDE; NOVOBIOCIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; BENZOQUINONE DERIVATIVE; CYTOKINE; HEAT SHOCK PROTEIN 90; HSP90AB1 PROTEIN, HUMAN; MACROCYCLIC LACTAM; NITRIC OXIDE DONOR; NITROPRUSSIDE SODIUM; NITROSO DERIVATIVE; NOC 12; SMALL INTERFERING RNA;

APOPTOSIS; ARTICLE; CARTILAGE CELL; CELL CULTURE; CELL STRUCTURE; CELL VIABILITY; CONTROLLED STUDY; DNA FRAGMENTATION; ENZYME INHIBITION; GENE EXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; OSTEOARTHRITIS; PATHOGENESIS; AGED; ARTICULAR CARTILAGE; CELL SURVIVAL; DRUG ANTAGONISM; DRUG EFFECT; FEMALE; GENETIC TRANSFECTION; GENETICS; KNEE OSTEOARTHRITIS; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY;

AGED; APOPTOSIS; BENZOQUINONES; CARTILAGE, ARTICULAR; CELL SURVIVAL; CELLS, CULTURED; CHONDROCYTES; CYTOKINES; FEMALE; GENE KNOCKDOWN TECHNIQUES; HSP90 HEAT-SHOCK PROTEINS; HUMANS; LACTAMS, MACROCYCLIC; MALE; MIDDLE AGED; NITRIC OXIDE; NITRIC OXIDE DONORS; NITROPRUSSIDE; NITROSO COMPOUNDS; NOVOBIOCIN; OSTEOARTHRITIS, KNEE; RNA, SMALL INTERFERING; TRANSFECTION;

EID: 80054076945     PISSN: None     EISSN: 14712474     Source Type: Journal    
DOI: 10.1186/1471-2474-12-237     Document Type: Article

References (33)

1. Pathology of osteoarthritis. Pritzker K, Osteoarthritis New York: Oxford University Press, Brandt K, Doherty M, Lohmander L, 1998 50 61
2. Biochemistry and metabolism of normal and osteoarthritic cartilage. Heinegard D, Bayliss M, Lorenzo P, Osteoarthritis New York: Oxford University Press, Brandt K, Doherty M, Lohmander L, 1998 74 84
3. Cytokine regulation of chondrocyte functions. Lotz M, Blanco F, von Kempis J, Dudler J, Maier R, Villiger P, Geng Y, J Rheumatol Suppl 1995 43 104 108 7752111
4. Proteomic analysis of human osteoarthritic chondrocytes reveals protein changes in stress and glycolysis. Ruiz-Romero C, Carreira V, Rego I, Remeseiro S, Lápez-Armada MJ, Blanco FJ, Proteomics 2008 8 3 495 507 10.1002/pmic.200700249 18186017 (Pubitemid 351252008)
5. Evidence that the 90-kDa heat shock protein is necessary for the steroid binding conformation of the L cell glucocorticoid receptor. Bresnick EH, Dalman FC, Sanchez ER, Pratt WB, J Biol Chem 1989 264 9 4992 4997 2647745 (Pubitemid 19092911)
6. Synergistic antileukemic interactions between 17-AAG and UCN-01 involve interruption of RAF/MEK- and AKT-related pathways. Jia W, Yu C, Rahmani M, Krystal G, Sausville EA, Dent P, Grant S, Blood 2003 102 1824 1832 United States 10.1182/blood-2002-12-3785 12738674 (Pubitemid 37022579)
7. Mutant conformation of p53 translated in vitro or in vivo requires functional HSP90. Blagosklonny MV, Toretsky J, Bohen S, Neckers L, Proc Natl Acad Sci USA 1996 93 16 8379 8383 10.1073/pnas.93.16.8379 8710879 (Pubitemid 26269566)
8. Protein-protein interactions controlling nitric oxide synthases. Kone BC, Acta Physiol Scand 2000 168 1 27 31 10.1046/j.1365-201x.2000.00629.x 10691776 (Pubitemid 30128664)
9. Targeting HSP90 for cancer therapy. Mahalingam D, Swords R, Carew JS, Nawrocki ST, Bhalla K, Giles FJ, Br J Cancer 2009 100 10 1523 1529 10.1038/sj.bjc.6605066 19401686
10. Phosphatase-1 and -2A inhibition modulates apoptosis in human osteoarthritis chondrocytes independently of nitric oxide production. Lápez-Armada M, Caramés B, Cillero-Pastor B, Lires-Deán M, Maneiro E, Fuentes I, Ruíz C, Galdo F, Blanco F, Ann Rheum Dis 2005 64 7 1079 1082 10.1136/ard.2004.034090 15958763 (Pubitemid 40909528)
11. IL-1-induced nitric oxide inhibits chondrocyte proliferation via PGE2. Blanco FJ, Lotz M, Exp Cell Res 1995 218 319 325 United States 10.1006/excr.1995.1161 7537695
12. Articular chondrocytes synthesize nitric oxide in response to cytokines and lipopolysaccharide. Stadler J, Stefanovic-Racic M, Billiar TR, Curran RD, McIntyre LA, Georgescu HI, Simmons RL, Evans CH, J Immunol 1991 147 11 3915 3920 1658153
13. Geldanamycin: the prototype of a class of antitumor drugs targeting the heat shock protein 90 family of molecular chaperones. Ochel HJ, Eichhorn K, Gademann G, Cell Stress Chaperones 2001 6 2 105 112 10.1379/1466-1268(2001) 006<0105:GTPOAC>2.0.CO;2 11599571 (Pubitemid 32522216)
14. Chondrocyte apoptosis induced by nitric oxide. Blanco FJ, Ochs RL, Schwarz H, Lotz M, Am J Pathol 1995 146 1 75 85 7856740
15. Hsp90: chaperoning signal transduction. Richter K, Buchner J, J Cell Physiol Wiley-Liss, Inc 2001 188 281 290 United States: 2001 10.1002/jcp.1131 11473354 (Pubitemid 32777169)
16. Hsp90{beta} and p130(cas): novel regulatory factors of MMP-13 expression in human osteoarthritic chondrocytes. Fan Z, Tardif G, Hum D, Duval N, Pelletier JP, Martel-Pelletier J, Ann Rheum Dis 2009 68 6 976 982 10.1136/ard.2008.092288 18593760
17. Hsp90 mediates insulin-like growth factor 1 and interleukin-1beta signaling in an age-dependent manner in equine articular chondrocytes. Boehm AK, Seth M, Mayr KG, Fortier LA, Arthritis Rheum 2007 56 7 2335 2343 10.1002/art.22664 17599753 (Pubitemid 47173581)
18. The chondroprotective agent ITZ-1 inhibits interleukin-1beta-induced matrix metalloproteinase-13 production and suppresses nitric oxide-induced chondrocyte death. Kimura H, Yukitake H, Suzuki H, Tajima Y, Gomaibashi K, Morimoto S, Funabashi Y, Yamada K, Takizawa M, J Pharmacol Sci 2009 110 2 201 211 10.1254/jphs.09076FP 19542681
19. ITZ-1, a client-selective Hsp90 inhibitor, efficiently induces heat shock factor 1 activation. Kimura H, Yukitake H, Tajima Y, Suzuki H, Chikatsu T, Morimoto S, Funabashi Y, Omae H, Ito T, Yoneda Y, et al. Chem Biol 2010 17 1 18 27 10.1016/j.chembiol.2009.12.012 20142037
20. Hsp90 inhibitors: clinical development and future opportunities in oncology therapy. Gao Z, Garcia-Echeverria C, Jensen MR, Curr Opin Drug Discov Devel 2010 13 2 193 202 20205053
21. Small molecule inhibitors of Hsp90 potently affect inflammatory disease pathways and exhibit activity in models of rheumatoid arthritis. Rice JW, Veal JM, Fadden RP, Barabasz AF, Partridge JM, Barta TE, Dubois LG, Huang KH, Mabbett SR, Silinski MA, et al. Arthritis Rheum 2008 58 12 3765 3775 10.1002/art.24047 19035474
22. Inhibitors of the HSP90 molecular chaperone: current status. Sharp S, Workman P, Adv Cancer Res United States 2006 95 323 348 16860662 (Pubitemid 44088424)
23. Novobiocin and additional inhibitors of the Hsp90 C-terminal nucleotide-binding pocket. Donnelly A, Blagg BS, Curr Med Chem 2008 15 26 2702 2717 10.2174/092986708786242895 18991631
24. The hsp90-related protein TRAP1 is a mitochondrial protein with distinct functional properties. Felts SJ, Owen BA, Nguyen P, Trepel J, Donner DB, Toft DO, J Biol Chem 2000 275 5 3305 3312 10.1074/jbc.275.5.3305 10652318 (Pubitemid 30083032)
25. Mitochondrial Dysregulation of Osteoarthritic Human Articular Chondrocytes Analyzed by Proteomics: a decrease in mitochondrial superoxide dismutase points to a redox imbalance. Ruiz-Romero C, Calamia V, Mateos J, Carreira V, Martínez-Gomariz M, Fernández M, Blanco FJ, Molecular & Cellular Proteomics 2009 8 1 172 189 10.1074/mcp.M800292-MCP200 22010275
26. Heat shock protein 90 as an endogenous protein enhancer of inducible nitric-oxide synthase. Yoshida M, Xia Y, J Biol Chem 2003 278 36953 36958 10.1074/jbc.M305214200 12855682 (Pubitemid 37140030)
27. Nitric oxide in osteoarthritis. Studer R, Jaffurs D, Stefanovic-Racic M, Robbins PD, Evans CH, Osteoarthritis Cartilage 1999 7 377 379 10.1053/joca.1998.0216 10419772 (Pubitemid 29331553)
28. Osteoarthritis and nitric oxide. Abramson SB, Osteoarthritis Cartilage 2008 16 Suppl. 2 15 20 18794013
29. Effect of nitric oxide on mitochondrial respiratory activity of human articular chondrocytes. Maneiro E, Lopez-Armada MJ, de Andres MC, Carames B, Martin MA, Bonilla A, Del Hoyo P, Galdo F, Arenas J, Blanco FJ, Ann Rheum Dis 2005 64 3 388 395 15708893 (Pubitemid 40283048)
30. Repression of heat shock transcription factor HSF1 activation by HSP90 (HSP90 complex) that forms a stress-sensitive complex with HSF1. Zou J, Guo Y, Guettouche T, Smith DF, Voellmy R, Cell 1998 94 4 471 80 10.1016/S0092-8674(00) 81588-3 9727490 (Pubitemid 28391863)
31. Chaperone regulation of the heat shock protein response. Voellmy R, Boellmann F, Adv Exp Med Biol 2007 594 89 99 10.1007/978-0-387-39975-1-9 17205678
32. Heat shock transcription factor-1 inhibits H2O2-induced apoptosis via down-regulation of reactive oxygen species in cardiac myocytes. Zhang L, Jiang H, Gao X, Zou Y, Liu M, Liang Y, Yu Y, Zhu W, Chen H, Ge J, Mol Cell Biochem 2011 347 1-2 21 8 10.1007/s11010-010-0608-1 20941531
33. Genome-wide analysis of human HSF1 signaling reveals a transcriptional program linked to cellular adaptation and survival. Page TJ, Sikder D, Yang L, Pluta L, Wolfinger RD, Kodadek T, Thomas RS, Mol Biosyst 2006 2 12 627 39 10.1039/b606129j 17216044 (Pubitemid 44772306)